179 related articles for article (PubMed ID: 32760217)
1. Overexpressed GATA3 enhances the sensitivity of colorectal cancer cells to oxaliplatin through regulating MiR-29b.
Wang W; Wang M; Xu J; Long F; Zhan X
Cancer Cell Int; 2020; 20():339. PubMed ID: 32760217
[TBL] [Abstract][Full Text] [Related]
2. Zuo Jin Wan Reverses the Resistance of Colorectal Cancer to Oxaliplatin by Regulating the MALAT1/miR-200s/JNK Signaling Pathway.
Wei Z; Zhou J; Yu H; Pu Y; Cheng Y; Zhang Y; Ji Q; Zhu H
Evid Based Complement Alternat Med; 2022; 2022():3032407. PubMed ID: 36248422
[TBL] [Abstract][Full Text] [Related]
3. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.
Zhou H; Lin C; Zhang Y; Zhang X; Zhang C; Zhang P; Xie X; Ren Z
Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28217977
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma.
Xu JX; Yang Y; Zhang X; Luan XP
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1922-1931. PubMed ID: 32141561
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of Mir-135b Sensitizes Colorectal Cancer Cells to Oxaliplatin-Induced Apoptosis Through Increase of FOXO1.
Qin Y; Li L; Wang F; Zhou X; Liu Y; Yin Y; Qi X
Cell Physiol Biochem; 2018; 48(4):1628-1637. PubMed ID: 30071508
[TBL] [Abstract][Full Text] [Related]
6. Exosomal transfer of circular RNA FBXW7 ameliorates the chemoresistance to oxaliplatin in colorectal cancer by sponging miR-18b-5p.
Xu Y; Qiu A; Peng F; Tan X; Wang J; Gong X
Neoplasma; 2021 Jan; 68(1):108-118. PubMed ID: 33147048
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-29b is a Novel Prognostic Marker in Colorectal Cancer.
Inoue A; Yamamoto H; Uemura M; Nishimura J; Hata T; Takemasa I; Ikenaga M; Ikeda M; Murata K; Mizushima T; Doki Y; Mori M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1410-8. PubMed ID: 25472644
[TBL] [Abstract][Full Text] [Related]
8. MiR-29b reverses oxaliplatin-resistance in colorectal cancer by targeting SIRT1.
Liu H; Cheng XH
Oncotarget; 2018 Feb; 9(15):12304-12315. PubMed ID: 29552311
[TBL] [Abstract][Full Text] [Related]
9. microRNA-29b inhibits cell growth and promotes sensitivity to oxaliplatin in colon cancer by targeting FOLR1.
Fu Q; Zhang J; Huang G; Zhang Y; Zhao M; Zhang Y; Xie J
Biofactors; 2020 Jan; 46(1):136-145. PubMed ID: 31621972
[TBL] [Abstract][Full Text] [Related]
10. miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity.
Hua Y; Zhu Y; Zhang J; Zhu Z; Ning Z; Chen H; Liu L; Chen Z; Meng Z
Cell Physiol Biochem; 2018; 51(5):2148-2159. PubMed ID: 30522111
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of circ_0000512 Inhibits Cell Proliferation and Promotes Apoptosis in Colorectal Cancer by Regulating miR-296-5p/RUNX1 Axis.
Wang L; Wu H; Chu F; Zhang L; Xiao X
Onco Targets Ther; 2020; 13():7357-7368. PubMed ID: 32821119
[TBL] [Abstract][Full Text] [Related]
12. miR-200b-3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer.
Wu YZ; Lin HY; Zhang Y; Chen WF
J Gene Med; 2020 Jul; 22(7):e3178. PubMed ID: 32092782
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of miR-96 enhances the sensitivity of colorectal cancer cells to oxaliplatin by targeting TPM1.
Ge T; Xiang P; Mao H; Tang S; Zhou J; Zhang Y
Exp Ther Med; 2020 Sep; 20(3):2134-2140. PubMed ID: 32765688
[TBL] [Abstract][Full Text] [Related]
14. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy
Sun C; Wang FJ; Zhang HG; Xu XZ; Jia RC; Yao L; Qiao PF
World J Gastroenterol; 2017 Mar; 23(10):1816-1827. PubMed ID: 28348487
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.
Yang S; Li W; Sun H; Wu B; Ji F; Sun T; Chang H; Shen P; Wang Y; Zhou D
BMC Cancer; 2015 Dec; 15():969. PubMed ID: 26674205
[TBL] [Abstract][Full Text] [Related]
16. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
[TBL] [Abstract][Full Text] [Related]
17. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637.
Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X
EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of microRNA-29b inhibits epithelial-mesenchymal transition and angiogenesis of colorectal cancer through the ETV4/ERK/EGFR axis.
Leng Y; Chen Z; Ding H; Zhao X; Qin L; Pan Y
Cancer Cell Int; 2021 Jan; 21(1):17. PubMed ID: 33407520
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats.
Zhong Y; Li YP; Yin YQ; Hu BL; Gao H
Int Immunopharmacol; 2020 Sep; 86():106768. PubMed ID: 32679539
[TBL] [Abstract][Full Text] [Related]
20. IFN-γ-mediated IRF1/miR-29b feedback loop suppresses colorectal cancer cell growth and metastasis by repressing IGF1.
Yuan L; Zhou C; Lu Y; Hong M; Zhang Z; Zhang Z; Chang Y; Zhang C; Li X
Cancer Lett; 2015 Apr; 359(1):136-47. PubMed ID: 25592039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]